Bionano Genomics announces presentation of OGM utility

Bionano Genomics announced its participation in the American Society of Human Genetics, ASHG, Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping, OGM, for cell bioprocessing quality control and constitutional genetic disorder research, including scientific platform and poster presentations from Bionano and researchers from across the genomics landscape. As part of a sponsored session, Dr. Brynn Levy of Columbia University Medical Center, Dr. Roger Stevenson, founder of Greenwood Genetic Center, and Dr. Alex Hastie, Bionano’s vice president of clinical and scientific affairs, will share their latest research covering the utility of OGM in constitutional genetic research. Dr. Levy will present findings from the largest multisite study to date comparing OGM to classical cytogenetic methods for postnatal constitutional disorder research. Dr. Stevenson will discuss his research using OGM for the analysis of neural tube defects. The session will take place on Thursday, November 2 at 12:30 PM ET in Room 143C.